Sakai Hiroyuki, Nagao Hidenori, Sakurai Mamoru, Okumura Takako, Nagai Yoshiyuki, Shikuma Junpei, Ito Rokuro, Imazu Tetsuya, Miwa Takashi, Odawara Masato
Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University, Tokyo, Japan.
Pharmacokinetics Research Department of ASKA Pharmaceutical Co., Ltd., Kawasaki, Kanagawa, Japan.
PLoS One. 2015 Oct 1;10(10):e0138864. doi: 10.1371/journal.pone.0138864. eCollection 2015.
For measuring serum 3,3',5'-triiodothyronine (rT3) levels, radioimmunoassay (RIA) has traditionally been used owing to the lack of other reliable methods; however, it has recently become difficult to perform. Meanwhile, liquid chromatography-tandem mass spectrometry (LC-MS/MS) has recently been attracting attention as a novel alternative method in clinical chemistry. To the best of our knowledge, there are no studies to date comparing results of the quantification of human serum rT3 between LC-MS/MS and RIA. We therefore examined the feasibility of LC-MS/MS as a novel alternative method for measuring serum rT3, thyroxine (T4), and 3,5,3'-triiodothyronine (T3) levels.
Assay validation was performed by LC-MS/MS using quality control samples of rT3, T4, and T3 at 4 various concentrations which were prepared from reference compounds. Serum samples of 50 outpatients in our department were quantified both by LC-MS/MS and conventional immunoassay for rT3, T4, and T3. Correlation coefficients between the 2 measurement methods were statistically analyzed respectively.
Matrix effects were not observed with our method. Intra-day and inter-day precisions were less than 10.8% and 9.6% for each analyte at each quality control level, respectively. Intra-day and inter-day accuracies were between 96.2% and 110%, and between 98.3% and 108.6%, respectively. The lower limit of quantification was 0.05 ng/mL. Strong correlations were observed between the 2 measurement methods (correlation coefficient, T4: 0.976, p < 0.001; T3: 0.912, p < 0.001; rT3: 0.928, p < 0.001).
Our LC-MS/MS system requires no manual cleanup operation, and the process after application of a sample is fully automated; furthermore, it was found to be highly sensitive, and superior in both precision and accuracy. The correlation between the 2 methods over a wide range of concentrations was strong. LC-MS/MS is therefore expected to become a useful tool for clinical diagnosis and research.
传统上,由于缺乏其他可靠方法,一直使用放射免疫分析法(RIA)来检测血清反三碘甲状腺原氨酸(rT3)水平;然而,最近该方法已难以实施。与此同时,液相色谱 - 串联质谱法(LC - MS/MS)作为临床化学中的一种新型替代方法,近来备受关注。据我们所知,目前尚无研究比较LC - MS/MS与RIA对人血清rT3定量检测的结果。因此,我们研究了LC - MS/MS作为检测血清rT3、甲状腺素(T4)和三碘甲状腺原氨酸(T3)水平的新型替代方法的可行性。
使用由参考化合物制备的4种不同浓度的rT3、T4和T3质量控制样品,通过LC - MS/MS进行分析方法验证。对本部门50名门诊患者的血清样品,同时采用LC - MS/MS和传统免疫分析法对rT3、T4和T3进行定量检测。分别对两种检测方法之间的相关系数进行统计学分析。
我们的方法未观察到基质效应。在每个质量控制水平下,各分析物的日内和日间精密度分别小于10.8%和9.6%。日内和日间准确度分别在96.2%至110%之间以及98.3%至108.6%之间。定量下限为0.05 ng/mL。两种检测方法之间观察到强相关性(相关系数,T4:0.976,p < 0.001;T3:0.912,p < 0.001;rT3:0.928,p < 0.001)。
我们的LC - MS/MS系统无需手动净化操作,进样后的过程完全自动化;此外,发现该系统高度灵敏,精密度和准确度均很出色。两种方法在较宽浓度范围内的相关性很强。因此,LC - MS/MS有望成为临床诊断和研究的有用工具。